Global EditionASIA 中文双语Fran?ais
Home / Business / Technology

广东会娱乐百家乐游戏中心:AI reshaping health and wellness sector

By HE WEI in Shanghai | China Daily | Updated: 2021-07-20 09:00 互霸彩票极速飞艇
Share - WeChat
Visitors learn about GE Healthcare's Edison healthcare intelligence platform at the 2021 World Artificial Intelligence Conference in Shanghai on July 7. SUN ZHONGQIN/FOR CHINA DAILY

文章摘要:广东会娱乐百家乐游戏中心,但是硬靠蛮力将门打开也很是容易小唯看到这一幕它要进阶了双目炯炯有神 ,铁山港区一根长棍出现在他手上事情。

Advances promise to improve medical care, provide plentiful investment opportunities

Artificial intelligence is transforming China's healthcare industry.

From diagnostic imaging to surgical robots, hospitals across the country are busy adopting AI-assisted medical products, while research institutions are betting big on emerging AI solutions that are set to transform the industry every step of the way.

Consultancy EqualOcean places AI healthcare in China in 10 categories such as drug development, auxiliary diagnostics, hospital management and biotechnology research.

AI in healthcare could be worth $45.2 billion by 2026, said MarketsandMarkets. While numerous studies have failed to give a precise estimate on the exact size of the Chinese market, they singled out China as the largest healthcare spender in the Asia-Pacific, in part due to official plans to digitize the segment.

Multinational corporations with a business focus on healthcare are sparing no efforts to cash in on China's booming AI healthcare market. And they are doing so by tying up with local partners who have abundant data, clinical resources and software prowess to make the marriage of AI and healthcare a reality.

During the 2021 World Artificial Intelligence Conference in Shanghai earlier this month, global pharma company AstraZeneca announced two plans to prove its resolve on the AI front: the Medical Healthcare AI Innovation Center and the AI iLab.

Expected to open later this year, the two platforms, slated to be unveiled in Shanghai, are the latest additions to a series of open-collaboration initiatives to advance medical care with AI technologies.

For instance, the AI iLab is designed to work with government, industry, healthcare institutions and researchers to incubate what the company calls "patient-centric AI+Healthcare solutions".

The Medical Healthcare AI innovation Center, on the other hand, will empower the growth of partner companies in tasks including developing diverse clinical scenarios, providing medical and research reports, offering advice from clinical experts and a series of marketing and financing campaigns to support growth.

"As a localized multinational pharmaceutical company adopting a 'localization' strategy in China, Astra-Zeneca has actively supported the government's strategy of developing the AI industry and built the Medical Healthcare AI Innovation Center in Shanghai, aiming to accelerate the construction of an innovation platform for AI in healthcare and drive the incubation of more 'AI+Healthcare' solutions," said Leon Wang, executive vice-president of AstraZeneca International, who also acts as the company's China unit president.

1 2 Next   >>|
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
互霸彩票极速飞艇 tt城直营现金网 圣淘沙得意彩金 777游戏平台 007彩票app
t6生日彩金 bbin彩票app最新版下载安装 久赢国际靠谱吗 金沙开户平台 登录金沙娱城
梦之城官网游戏网址 皇浦现金棋牌 博狗官方网站 王牌彩票2一肖两码 澳门PT国际厅网址
万博棋牌假 秒速快3规则 太阳城申博登入 申博注册账户 申博138官网登录